MREO
Closed
Mereo Biopharma Group Plc Adr
2.76
+0.05 (+1.85%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.71
Day's Range: 2.6604 - 2.86
Send
sign up or login to leave a comment!
When Written:
0.8883
Mereo BioPharma Group PLC is a clinical-stage biopharmaceutical company that focuses on developing and commercializing innovative therapeutics for rare and specialty diseases. The company's pipeline includes several product candidates in various stages of development, targeting diseases such as osteogenesis imperfecta, alpha-1 antitrypsin deficiency, and hypogonadotropic hypogonadism. Mereo BioPharma Group PLC is headquartered in London, UK, and its American Depositary Receipts (ADRs) trade on the NASDAQ stock exchange under the ticker symbol "MREO."
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








